| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.33 | 2e-14 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.29 | 2e-10 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.03 |